Amongst people with HF, up to 50% are estimated to have type 2 diabetes and, vice versa, around 20% of the over 500 million people living with type 2 diabetes have been shown to have comorbid HF (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not
Your healthcare provider may also use it to treat panic disorder or panic attacks, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD)
Large randomized trials evaluating liraglutide, semaglutide, and dulaglutide consistently demonstrate reductions in major adverse cardiovascular events, including myocardial infarction, stroke, and cardiovascular death
This includes getting enough exercise, eating a diet rich in protein and fiber and making behavioral changes that promote better eating habits
People with heart problems may need to have regular ECGs to monitor Lexapros effects on the heart